Learn About Dilated Cardiomyopathy with Hypergonadotropic Hypogonadism

What is the definition of Dilated Cardiomyopathy with Hypergonadotropic Hypogonadism?
Dilated cardiomyopathy with hypergonadotropic hypogonadism (DCMHH) is a condition that primarily affects the heart and gonads (male testes or female ovaries). It is characterized by a disease of the heart muscle (dilated cardiomyopathy) and little or no production of sex hormones due to a problem with the pituitary gland or hypothalamus (hypergonadotropic hypogonadism). Other symptoms might include: characteristic facial features, intellectual disability, mild skeletal anomalies, and abnormalities of the metabolic system. Some cases of DCMHH are caused by genetic changes in the LMNA gene. Both autosomal dominant and autosomal recessive inheritance patterns have been described.
Save information for later
Sign Up
What are the alternative names for Dilated Cardiomyopathy with Hypergonadotropic Hypogonadism?
  • Dilated cardiomyopathy with hypergonadotropic hypogonadism
  • Cardiogenital syndrome
  • Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome
  • Genital anomaly with cardiomyopathy
  • Malouf syndrome
  • Najjar syndrome
Who are the top Dilated Cardiomyopathy with Hypergonadotropic Hypogonadism Local Doctors?
Distinguished
Highly rated in
6
conditions

Royal Victoria Infirmary

London, ENG, GB 

Claire Wood is in London, United Kingdom. Wood is rated as a Distinguished expert by MediFind in the treatment of Dilated Cardiomyopathy with Hypergonadotropic Hypogonadism. She is also highly rated in 6 other conditions, according to our data. Her top areas of expertise are Dilated Cardiomyopathy with Hypergonadotropic Hypogonadism, Cardiomyopathy Hypogonadism Metabolic Anomalies, Duchenne Muscular Dystrophy, and Becker Muscular Dystrophy.

Distinguished
Highly rated in
12
conditions

Great North Children's Hospital

University Of Cambridge Metabolic Research Laboratories And National Institute For Health Research Cambridge Biomedical Research Centre, Addenbrooke's Hospital, Cambridge, The Exeter Centre Of Excellence For Diabetes Research, University Of Exeter Medical School, Birmingham, Broomfield Hospital, Hull, East And North Hertfordshire Nhs Trust Lister Hospital, Darlington, Nottingham Children's Hospital, London, The Translational And Clinical Research Institute, Newcastle University, And Great North Children's Hospital, Bristol And The Division Of Developmental Biology And Medicine 
Manchester, ENG, GB 

Tim Cheetham is in Manchester, United Kingdom. Cheetham is rated as a Distinguished expert by MediFind in the treatment of Dilated Cardiomyopathy with Hypergonadotropic Hypogonadism. He is also highly rated in 12 other conditions, according to our data. His top areas of expertise are Dilated Cardiomyopathy with Hypergonadotropic Hypogonadism, Cardiomyopathy Hypogonadism Metabolic Anomalies, Hyperthyroidism, and Graves Disease.

 
 
 
 
Learn about our expert tiers
Learn more
Distinguished
Highly rated in
37
conditions

Newcastle Hospitals NHS Foundation Trust

John Walton Muscular Dystrophy Research Centre 
Newcastle Upon Tyne, ENG, GB 

Volker Straub is in Newcastle Upon Tyne, United Kingdom. Straub is rated as a Distinguished expert by MediFind in the treatment of Dilated Cardiomyopathy with Hypergonadotropic Hypogonadism. He is also highly rated in 37 other conditions, according to our data. His top areas of expertise are Limb-Girdle Muscular Dystrophy, Becker Muscular Dystrophy, Duchenne Muscular Dystrophy, and Dysferlinopathy.

What are the latest Dilated Cardiomyopathy with Hypergonadotropic Hypogonadism Clinical Trials?
Coordination of Rare Diseases at Sanford
Match to trials
Find the right clinical trials for you in under a minute
Get started
Piloting an Early Intervention Program for Infants With Rare Neurogenetic Disorders
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center

What are the Latest Advances for Dilated Cardiomyopathy with Hypergonadotropic Hypogonadism?
Observational study of clinical outcomes for testosterone treatment of pubertal delay in Duchenne muscular dystrophy.
Tired of the same old research?
Check Latest Advances